Cost–utility analysis of interventions to improve effectiveness of exercise therapy for adults with knee osteoarthritis: the BEEP trial

Abstract Objectives Evidence regarding the cost-effectiveness of enhancing physical therapy exercise programmes in order to improve outcomes for patients with knee OA remains unclear. This study investigates the cost-effectiveness of two enhanced physical therapy interventions compared with usual physical therapy care (UC) for adults with knee OA. Methods A trial-based cost–utility analysis of individually tailored exercise (ITE) or targeted exercise adherence (TEA) compared with UC was undertaken over a period of 18 months. Patient-level costs were obtained, and effectiveness was measured in terms of quality-adjusted life years (QALYs), allowing the calculation of cost per QALY gained from a base-case UK health-care perspective. Results The UC group was associated with lower National Health Service (NHS) costs [ITE-UC: £273.30, 95% CI: £−62.10 to £562.60; TEA-UC: £141.80, 95% CI: £−135.60 to £408.10)] and slightly higher QALY gains (ITE-UC: −0.015, 95% CI: −0.057 to 0.026; TEA-UC: −0.003, 95% CI: −0.045 to 0.038). In the base case, UC was the most likely cost-effective option (probability <40% of ITE or TEA cost-effective at £20 000/QALY). Differences in total costs were attributable to intervention costs, number of visits to NHS consultants and knee surgery, which were higher in both ITE and TEA groups. Conclusion This is the first economic evaluation comparing usual physical therapy care vs enhanced exercise interventions for knee OA that involves greater exercise individualization, supervision and progression or that focuses on exercise and physical activity adherence over the longer term. Our findings show that UC is likely to be the most cost-effective option. Trial registration Current Controlled Trials ISRCTN 93634563. Trial protocol Full details of the trial protocol can be found in the Supplementary Appendix, available with the full text of this article at http://www.biomedcentral.com/1471-2474/15/254 doi: 10.1186/1471-2474-15-254

[1]  N. Foster,et al.  Content and Evaluation of the Benefits of Effective Exercise for Older Adults With Knee Pain Trial Physiotherapist Training Program. , 2017, Archives of physical medicine and rehabilitation.

[2]  D. A. van der Windt,et al.  Pain trajectory groups in persons with, or at high risk of, knee osteoarthritis: findings from the Knee Clinical Assessment Study and the Osteoarthritis Initiative , 2014, Osteoarthritis and cartilage.

[3]  N. Foster,et al.  A multicentre, pragmatic, parallel group, randomised controlled trial to compare the clinical and cost-effectiveness of three physiotherapy-led exercise interventions for knee osteoarthritis in older adults: the BEEP trial protocol (ISRCTN: 93634563) , 2014, BMC Musculoskeletal Disorders.

[4]  C. Juhl,et al.  Impact of Exercise Type and Dose on Pain and Disability in Knee Osteoarthritis: A Systematic Review and Meta‐Regression Analysis of Randomized Controlled Trials , 2014, Arthritis & rheumatology.

[5]  P. Larmer,et al.  Systematic review of guidelines for the physical management of osteoarthritis. , 2014, Archives of physical medicine and rehabilitation.

[6]  P. Hansen,et al.  Manual therapy, exercise therapy, or both, in addition to usual care, for osteoarthritis of the hip or knee. 2: economic evaluation alongside a randomized controlled trial. , 2013, Osteoarthritis and cartilage.

[7]  O. Uthman,et al.  Exercise for lower limb osteoarthritis: systematic review incorporating trial sequential analysis and network meta-analysis , 2013, BMJ : British Medical Journal.

[8]  J. Cobb,et al.  The Global Economic Cost of Osteoarthritis: How the UK Compares , 2012, Arthritis.

[9]  C. Helmick,et al.  The Impact of Osteoarthritis in the United States: A Population-Health Perspective , 2012, The American journal of nursing.

[10]  N. Walsh,et al.  Long‐term outcomes and costs of an integrated rehabilitation program for chronic knee pain: A pragmatic, cluster randomized, controlled trial , 2012, Arthritis care & research.

[11]  P. Hansen,et al.  Cost-effectiveness of nonpharmacologic, nonsurgical interventions for hip and/or knee osteoarthritis: systematic review. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[12]  G. Oster,et al.  Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis. , 2011, Arthritis and rheumatism.

[13]  C. Jinks,et al.  Inequalities in primary care management of knee pain and disability in older adults: an observational cohort study , 2011, Rheumatology.

[14]  J. Arokoski,et al.  A pragmatic randomized controlled study of the effectiveness and cost consequences of exercise therapy in hip osteoarthritis , 2011, Clinical rehabilitation.

[15]  R. Hinman,et al.  A review of the clinical evidence for exercise in osteoarthritis of the hip and knee. , 2011, Journal of science and medicine in sport.

[16]  J. Severens,et al.  The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[17]  Christopher G. Maher,et al.  Exercise for Osteoarthritis of the Knee , 2010, Physical Therapy.

[18]  N. Foster,et al.  Physical Therapists’ Use of Therapeutic Exercise for Patients With Clinical Knee Osteoarthritis in the United Kingdom: In Line With Current Recommendations? , 2008, Physical Therapy.

[19]  Martin Underwood,et al.  Osteoarthritis: national clinical guideline for care and management in adults , 2008 .

[20]  L. Curtis,et al.  Unit Costs of Health and Social Care 2016 , 2015 .

[21]  P. Dieppe,et al.  Economic evaluation of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain , 2007, Arthritis and rheumatism.

[22]  David Parkin,et al.  Economic Analysis in Health Care , 2007 .

[23]  P. Brooks.  The burden of musculoskeletal disease—a global perspective , 2006, Clinical Rheumatology.

[24]  A. Silman,et al.  Cost-effectiveness of a supplementary class-based exercise program in the treatment of knee osteoarthritis , 2006, International Journal of Technology Assessment in Health Care.

[25]  R. Davey,et al.  Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis. , 2005, Health Technology Assessment.

[26]  Elisabeth Fenwick,et al.  A guide to cost-effectiveness acceptability curves. , 2005, The British journal of psychiatry : the journal of mental science.

[27]  M. Sculpher,et al.  Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. , 2005, Health economics.

[28]  A. Silman,et al.  Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis. , 2004, Health technology assessment.

[29]  S. Mason,et al.  EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. , 2004, Health technology assessment.

[30]  C. Jinks,et al.  A brief screening tool for knee pain in primary care (KNEST). 2. Results from a survey in the general population aged 50 and over. , 2004, Rheumatology.

[31]  R. McCarney,et al.  Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care , 2001, Annals of the rheumatic diseases.

[32]  M. Sevick,et al.  Cost-effectiveness of aerobic and resistance exercise in seniors with knee osteoarthritis. , 2000, Medicine and science in sports and exercise.

[33]  J. Schafer.  Multiple imputation: a primer , 1999, Statistical methods in medical research.

[34]  A Briggs,et al.  Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. , 1998, Health economics.

[35]  S G Thompson,et al.  Analysis and interpretation of cost data in randomised controlled trials: review of published studies , 1998, BMJ.

[36]  L. March,et al.  10 Economics of osteoarthritis: a global perspective , 1997 .

[37]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[38]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[39]  L. March,et al.  Economics of osteoarthritis: a global perspective. , 1997, Bailliere's clinical rheumatology.

[40]  R. Brooks.  EuroQol: the current state of play. , 1996, Health policy.

[41]  M J Al,et al.  Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.

[42]  A. B. Prasad,et al.  British National Formulary , 1994 .

[43]  C. Goldsmith,et al.  Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. , 1988, The Journal of rheumatology.

[44]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .